Copyright
©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 134-141
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.134
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.134
Variable1 | HR | 95%CI | P value |
Transplant received | |||
SLK | ref. | ||
LTA | 2.85 | (2.21, 3.66) | < 0.001 |
Transplant center SLK volume2 | |||
Interaction with receiving LTA vs SLK | 0.97 | (0.95, 0.99) | 0.010 |
Age (yr) | 1.01 | (1.01, 1.02) | < 0.001 |
Male | 1.08 | (0.94, 1.24) | 0.285 |
Race | |||
White | ref. | ||
Black | 1.17 | (0.98, 1.39) | 0.089 |
Other | 0.79 | (0.66, 0.94) | 0.007 |
Etiology of liver disease | |||
Viral | ref. | ||
Cryptogenic | 0.77 | (0.61, 0.98) | 0.033 |
Autoimmune | 0.57 | (0.41, 0.79) | 0.001 |
NASH | 0.79 | (0.63, 1.01) | 0.060 |
Alcoholic | 0.65 | (0.54, 0.77) | < 0.001 |
HCC | 1.04 | (0.83, 1.30) | 0.721 |
AHN | 1.10 | (0.75, 1.63) | 0.621 |
Other | 0.77 | (0.62, 0.97) | 0.024 |
Diabetes | 1.23 | (1.08, 1.40) | 0.002 |
Dialysis | 1.41 | (1.19, 1.67) | < 0.001 |
BMI (kg/m2) | 0.98 | (0.97, 0.99) | 0.003 |
Serum creatinine (mg/dL) | 0.97 | (0.93, 1.01) | 0.092 |
Bilirubin (mg/dL) | 1.00 | (0.98, 1.01) | 0.394 |
Albumin (mg/dL) | 0.88 | (0.81, 0.96) | 0.004 |
INR | 0.92 | (0.81, 1.05) | 0.224 |
MELD score | 1.00 | (0.99, 1.02) | 0.661 |
eGFR | 1.00 | (1.00, 1.01) | 0.622 |
Hepatic encephalopathy on wait list | 1.10 | (0.94, 1.28) | 0.221 |
Liver allograft cold ischemia time | 1.00 | (0.98, 1.02) | 0.811 |
Year of transplant | 0.98 | (0.96, 1.00) | 0.107 |
- Citation: Modi RM, Tumin D, Kruger AJ, Beal EW, Hayes Jr D, Hanje J, Michaels AJ, Washburn K, Conteh LF, Black SM, Mumtaz K. Effect of transplant center volume on post-transplant survival in patients listed for simultaneous liver and kidney transplantation. World J Hepatol 2018; 10(1): 134-141
- URL: https://www.wjgnet.com/1948-5182/full/v10/i1/134.htm
- DOI: https://dx.doi.org/10.4254/wjh.v10.i1.134